Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study Deltamotion - DAA THA Study

NCT01474031 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.

NCT NCT01474031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01474031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study Deltamotion - DAA THA Study
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Phase
Observational
Overall status
Terminated
Start date
October 31, 2011
Completion date
July 31, 2013
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthrosis